DUBLIN--(BUSINESS WIRE)-- <\/p>\n
Research and Markets (http:\/\/www.researchandmarkets.com\/research\/5ckx7v\/us_personalized<\/a>) has announced the addition of the \"US Personalized Cancer Genome Sequencing Market\" report to their offering. <\/p>\n The US personalized cancer Whole-Genome Sequencing market is primarily classified into targeted genome sequencing and Whole-Genome Sequencing. Our report entitled US Personalized Cancer Genome Sequencing Market takes into account the Whole-Genome Sequencing services, i.e. one of the most attractive sectors due to its inherent capability of high revenue generation and efficiency in terms of personalized treatment. The US, which is the frontrunner in the provision of such high-end service, is on the focus by market players because of favorable demographics and rising awareness among the industry participants. <\/p>\n In order to properly analyze the virtues and significance of the US personalized cancer Whole-Genome Sequencing market, our report has effectively studied the current and future status of cancer in the whole country as well as states. In view of the fact that cancer affects some age groups in a significant manner, we have also investigated the age wise statistics of the disease. To get proper insight into the market, an in-depth analysis into the high-income group population is provided so that players can have a clear picture about their potential customer base and market to be tapped. <\/p>\n An in-depth study of the regulatory environment governing the US personalized cancer Whole-Genome Sequencing market has also been provided. It has been found that regulations related to personalized cancer sequencing are primarily governed with the accreditation of the laboratories performing the sequencing services and analysis and also the usage of FDA approved tests for conducting these tests. Further we have also discussed the various constraints faced by the industry players with suitable suggestions for overcoming them. <\/p>\n Companies Mentioned: <\/p>\n - Illumina <\/p>\n - Complete Genomics <\/p>\n - Beckman Coulter Genomics <\/p>\n - Expression Analysis <\/p>\n<\/p>\n Continue reading here: DUBLIN--(BUSINESS WIRE)-- Research and Markets (http:\/\/www.researchandmarkets.com\/research\/5ckx7v\/us_personalized<\/a>) has announced the addition of the \"US Personalized Cancer Genome Sequencing Market\" report to their offering. The US personalized cancer Whole-Genome Sequencing market is primarily classified into targeted genome sequencing and Whole-Genome Sequencing. Our report entitled US Personalized Cancer Genome Sequencing Market takes into account the Whole-Genome Sequencing services, i.e. Continue reading
\nResearch and Markets: US Personalized Cancer Genome Sequencing Market<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"